You are viewing the site in preview mode

Skip to main content

Advertisement

Table 3 Evaluation of synergy: time killing curves on 5 MRSA strains

From: In vitro evaluation of antibiotics' combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureussevere respiratory infections

Combination Nr of strains showing synergy/indifference at:
  2 h 6 h 12 h 24 h
LVX + VA 0/5 0/5 2/3 5
LVX + TEC 0/5 0/5 3/2 5/0
CTX + VA 0/5 1/4 5/0 5/0
CTX + TEC 0/5 0/5 5/0 5/0
LVX + VA + AMK 0/5 0/5 0/5 3/2
LVX + TEC + AMK 0/5 0/5 0/5 4/1
LVX + VA + CAZ 0/5 0/5 0/5 2/3
LVX + TEC + CAZ 0/5 1/4 2/3 3/2
LVX + VA + FEP 0/5 0/5 0/5 3/2
LVX + TEC + FEP 0/5 0/5 1/4 3/2
LVX + VA + IPM 0/5 0/5 1/4 3/2
LVX + TEC + IPM 0/5 1/4 2/3 3/2
LVX + VA + TZP 0/5 0/5 2/3 2/3
LVX + TEC + TZP 0/5 0/5 3/2 3/2
  1. LVX: levofloxacin; VA: vancomycin; TEC: teicoplanin; CTX: cefotaxime; AMK: amikacin; CAZ: ceftazidime; FEP: cefepime; IPM: imipenem; TZP: piperacillin/tazobactam.